ArticleClinicoEconomics and outcomes research : CEOR2020
Economic Burden of Malaria and Associated Factors Among Rural Households in Chewaka District, Western Ethiopia.
Article in ClinicoEconomics and outcomes research : CEOR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The economic burden of malaria in Africa: a systematic review of cost of illness studies.Malaria journal · 2025Pooled it
- The economic burden of malaria: a systematic review.Malaria journal · 2022Pooled it
- The social experience of malaria treatment-seeking: pathways, gender, and inequality in Jimma Zone, Ethiopia.Malaria journal · 2026Article
- Economic burden of malaria in children under the age of five in Burundi.Malaria journal · 2025Article
- Evaluation of anti-malarial treatment for elimination of malaria in South West Ethiopia: a concurrent triangulation design for prompt decision.Malaria journal · 2025Article
- Epidemiological characteristics and molecular identification ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024Article
- Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases ofAntibodies (Basel, Switzerland) · 2024Article
- Effect of Socio-economic factors on malaria prevalence in a Peri-urban setting in Vihiga County, Western Kenya Highlands.African health sciences · 2024Article
- Malaria control and elimination in Kenya: economy-wide benefits and regional disparities.Malaria journal · 2023Article
- Economic evaluation of severe malaria in children under 14 years in Zambia.Cost effectiveness and resource allocation : C/E · 2022Article
- The economic burden of malaria inpatients and its determinants during China's elimination stage.Frontiers in public health · 2022Article
- Determinants of Malaria Morbidity Among School-Aged Children Living in East Hararghe Zone, Oromia, Ethiopia: A Community-Based Case-Control Study.Pediatric health, medicine and therapeutics · 2022Article
- Sub-national disparities in accessing anti-malarial drug treatment in eastern Indonesia.BMC public health · 2021Article
- Mapping socioeconomic inequalities in malaria in Sub-Sahara African countries.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere has been a remarkable decline in the burden of malaria in the past few decades in Ethiopia. However, malaria remains a major impediment to both health and economic development in Ethiopia, with 60% of the population at risk of contracting malaria. Hence, this study aimed to estimate the economic burden of malaria among rural households in Chewaka district, Buno Bedele zone, Oromia regional state, Western Ethiopia.
methodsCommunity-based cross-sectional study design was employed to estimate the economic burden of malaria at the household level from August 13 to September 2, 2018. A retrospective costing approach was employed, and cost was estimated from the perspective of households. The study included malaria expenditure of households during a one-year period (July 9, 2017 to July 9, 2018). Data were collected from 765 randomly selected households and analyzed using SPSS version 20. Multivariate logistic regression analysis was performed to identify predictors of the economic burden of malaria among rural households and all variables with P-value <0.05 were considered as statistically significant at 95% CI.
resultsOn average, each household comprised 2 malaria cases (SD 1.1) in the past one-year period and the prevalence of malaria in the study setting was 32% (95% CI, 30.5-33.2). The average annual income of households was US$626.7 (95% CI, 590.4-663.0). The mean annual cost of malaria illness to households was US$16 (95% CI, 14.8-17.2), and most of this cost (78%) was contributed by the indirect costs. In every household, on average, patients and companions or caregivers lost 3.4 productive workdays due to malaria illness, respectively. Fourteen households out of 100 spent more than 5% of their annual income on malaria treatment and hence, they were prone to high economic burden or catastrophic costs. Household level economic burden of malaria was determined by the sex and educational status of household head, means of transportation to treatment center, the episodes of malaria, the number of malaria "ill days" and type of malaria diagnosis.
conclusionMalaria continues to significantly impose an economic burden on the rural households of Ethiopia. Hence, the national malaria program needs to recognize and address the catastrophic costs associated with malaria illness. Efforts should be made to ensure universal access to and utilization of malaria prevention, diagnosis, and treatment services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.